Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Ajanta Pharma Ltd Financial Statements & Historical Data

Updated NSE: AJANTPHARMBSE: 532331
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 8:04 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price3,525₹ per share
Reported P/E38.8Times
Book value per share362₹ per share
Reported ROCE34.5 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 8:04 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap44,039 Cr.
Current Price3,525
High / Low3,797/2,330
Stock P/E38.8
Book Value362
Dividend Yield0.91 %
ROCE34.5 %
ROE27.1 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Ajanta Pharma Ltd 44,039 Cr. 3,525 3,797/2,33038.8 3620.91 %34.5 %27.1 % 2.00
Gland Pharma Ltd 47,817 Cr. 2,896 3,042/1,57433.8 6560.69 %17.4 %12.8 % 1.00
Ipca Laboratories Ltd 48,726 Cr. 1,919 2,039/1,25235.5 3180.31 %17.0 %15.7 % 1.00
Glaxosmithkline Pharmaceuticals Ltd 49,047 Cr. 2,896 3,121/2,08846.6 1341.97 %61.4 %45.6 % 10.0
J B Chemicals & Pharmaceuticals Ltd 38,677 Cr. 2,409 2,526/1,60353.8 2590.91 %25.4 %18.9 % 1.00
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Ajanta Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 9728821,0211,0281,1051,0541,1451,1871,1461,1701,3031,3541,3751,4221,626
Expenses 8027327507387917768158758258739511,0269931,0881,202
Operating Profit 170149271291314278330311321297351328382333424
OPM % 17%17%27%28%28%26%29%26%28%25%27%24%28%23%26%
Other Income 353732211436261930182659256171
Interest 311222168653523
Depreciation 333333343434343436404143444544
Profit before tax 168152269276291278322290307269331341359347447
Tax % 20%20%23%29%28%27%24%25%24%16%23%24%24%23%25%
Net Profit 135122208195210203246216233225255260274267334
EPS in Rs 10.509.5416.2415.2416.3915.8219.6817.3318.6418.0320.4420.8321.9121.3526.75

Last Updated: September 26, 2026, 9:57 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 9:57 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1,2081,4741,7491,9832,1262,0552,5882,8903,3413,7434,2094,6485,4535,776
Expenses 8409681,1551,2921,4671,4891,9041,8892,4082,9343,0373,3793,9534,309
Operating Profit 3695055946916585676831,0019338081,1721,2691,5001,467
OPM % 31%34%34%35%31%28%26%35%28%22%28%27%28%25%
Other Income 14814202421882411274858567217
Interest 9651011281067211614
Depreciation 44524461607296116125131135144173176
Profit before tax 3304565596486235146649009097451,1141,1891,3781,493
Tax % 29%32%26%22%25%25%30%27%22%21%27%23%23%
Net Profit 2343104165074693874686547135888169201,0561,135
EPS in Rs 17.7523.4731.4938.4035.5029.5635.7350.3855.6345.8963.7073.6884.5290.84
Dividend Payout % 15%17%17%23%0%20%24%13%11%15%79%38%33%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)32.48%34.19%21.88%-7.50%-17.48%20.93%39.74%9.02%-17.53%38.78%12.75%14.78%
Change in YoY Net Profit Growth (%)0.00%1.71%-12.32%-29.37%-9.99%38.41%18.81%-30.72%-26.55%56.31%-26.03%2.04%

Ajanta Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:12%
3 Years:12%
TTM:11%
Compounded Profit Growth
10 Years:11%
5 Years:14%
3 Years:9%
TTM:9%
Stock Price CAGR
10 Years:11%
5 Years:21%
3 Years:25%
1 Year:-19%
Return on Equity
10 Years:24%
5 Years:22%
3 Years:22%
Last Year:25%

Last Updated: September 4, 2025, 10:30 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 27, 2026, 2:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 181818181818171725252525
Reserves 8231,1731,5502,0242,2282,5812,9783,2473,3633,5423,7654,502
Borrowings 72811236753125363547260
Other Liabilities 2332072543833836197027111,1599271,0671,250
Total Liabilities 1,1461,4791,8232,4262,6643,2933,7294,0004,5824,5304,9046,037
Fixed Assets 2884515891,0531,1781,4721,5411,5121,4961,4791,7621,867
CWIP 17024033961262132108153209256176258
Investments 60861821907879176147535349464588
Other Assets 6297037131,1221,1471,6101,9042,1882,3412,4462,5023,324
Total Assets 1,1461,4791,8232,4262,6643,2933,7294,0004,5824,5304,9046,037
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 2793266092813754575765627927851,157529
Cash from Investing Activity + -158-209-383-256-223-224-282-74-56065-377-429
Cash from Financing Activity + -105-117-202-0-147-129-318-460-108-1,051-733-168
Net Cash Flow 16-024254104-2428124-20147-68
Free Cash Flow 176293131932228417431618646840169
CFO/OP 84%82%110%64%87%89%81%86%117%94%117%59%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow176.0029.00313.0019.0032.00228.00417.00431.00618.00646.00840.00169.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 6164785979821099311110310893
Inventory Days 164159180186315415276434347283283308
Days Payable 132109128157224214202212143147159155
Cash Conversion Cycle 9411413088170282184315315240233246
Working Capital Days 395678651031131081261408311997
ROCE %55%57%52%46%34%24%27%32%29%23%32%32%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 66.22%66.22%66.22%66.27%66.26%66.26%66.26%66.26%66.25%66.25%66.25%63.49%
FIIs 9.99%9.11%8.54%8.36%9.11%9.26%8.86%8.86%8.53%7.97%8.26%7.68%
DIIs 15.60%16.67%17.48%17.41%17.09%17.02%17.48%17.50%17.90%18.58%18.36%21.80%
Government 0.00%0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.00%
Public 8.21%8.00%7.76%7.94%7.51%7.45%7.38%7.38%7.32%7.20%7.14%7.03%
No. of Shareholders 56,27754,35155,48870,31664,31566,89670,82768,88267,78565,40967,95565,296
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund 1,674,471 0.71 465.821,977,7442025-12-08 07:42:13-15.33%
UTI Flexi Cap Fund 1,414,000 1.67 393.361,425,0002026-01-25 06:31:44-0.77%
Kotak Small Cap Fund 1,219,302 2.07 339.2N/AN/AN/A
Nippon India Pharma Fund 959,323 3.39 266.87968,2142025-12-08 04:19:42-0.92%
HDFC Large and Mid Cap Fund 897,224 0.88 249.6N/AN/AN/A
Canara Robeco Large and Mid Cap Fund 877,439 0.99 244.09878,5062026-02-23 01:29:43-0.12%
UTI Mid Cap Fund 831,388 2.01 231.28836,3882026-02-23 01:29:43-0.6%
Nippon India Multi Cap Fund 807,460 0.46 224.63628,9662025-12-08 02:19:2728.38%
Canara Robeco Small Cap Fund 747,040 1.64 207.82698,0372026-02-23 01:29:437.02%
Kotak Large & Midcap Fund 500,000 0.46 139.1N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 73.5664.8245.8982.4575.09
Diluted EPS (Rs.) 73.5364.7745.8982.4575.09
Cash EPS (Rs.) 84.9275.3156.8997.6188.55
Book Value[Excl.RevalReserv]/Share (Rs.) 302.38282.34268.14380.24344.52
Book Value[Incl.RevalReserv]/Share (Rs.) 302.38282.34268.14380.24344.52
Revenue From Operations / Share (Rs.) 370.81333.10296.21389.17332.34
PBDIT / Share (Rs.) 108.0299.4569.80121.72117.83
PBIT / Share (Rs.) 96.5288.7359.45107.13104.48
PBT / Share (Rs.) 94.8788.1658.98105.94103.53
Net Profit / Share (Rs.) 73.4364.6046.5483.0175.20
NP After MI And SOA / Share (Rs.) 73.4364.6046.5483.0175.20
PBDIT Margin (%) 29.1329.8523.5631.2735.45
PBIT Margin (%) 26.0226.6320.0627.5231.43
PBT Margin (%) 25.5826.4619.9127.2231.15
Net Profit Margin (%) 19.8019.3915.7121.3322.62
NP After MI And SOA Margin (%) 19.8019.3915.7121.3322.62
Return on Networth / Equity (%) 24.2822.8717.3521.8321.82
Return on Capital Employeed (%) 30.1029.9521.2126.9829.02
Return On Assets (%) 18.3517.5912.5617.5717.30
Asset Turnover Ratio (%) 0.960.900.810.830.79
Current Ratio (X) 2.853.052.493.503.13
Quick Ratio (X) 1.952.121.772.281.94
Inventory Turnover Ratio (X) 5.371.141.191.101.25
Dividend Payout Ratio (NP) (%) 38.0078.6815.2511.5312.67
Dividend Payout Ratio (CP) (%) 32.8567.4812.479.8110.76
Earning Retention Ratio (%) 62.0021.3284.7588.4787.33
Cash Earning Retention Ratio (%) 67.1532.5287.5390.1989.24
Interest Coverage Ratio (X) 65.32174.28151.01102.45123.89
Interest Coverage Ratio (Post Tax) (X) 45.40114.20101.6870.8780.07
Enterprise Value (Cr.) 32649.2528149.1114945.6115321.6715384.30
EV / Net Operating Revenue (X) 7.026.693.994.595.32
EV / EBITDA (X) 24.1122.4016.9514.6615.02
MarketCap / Net Operating Revenue (X) 7.066.724.084.655.40
Retention Ratios (%) 61.9921.3184.7488.4687.32
Price / BV (X) 8.667.934.514.765.21
Price / Net Operating Revenue (X) 7.066.724.084.655.40
EarningsYield 0.020.020.030.040.04
Advertisements
Explore Industry-wise Company financial data